Mostrar el registro sencillo del ítem

Artículo

dc.creatorZhao, Yichaoes
dc.creatorTabet, Danieles
dc.creatorRubio Contreras, Dianaes
dc.creatorLao, Linjianges
dc.creatorKousholt, Arne Nedergaardes
dc.creatorWeile, Jochenes
dc.creatorGómez Herreros, Fernandoes
dc.creatorDurocher, Danieles
dc.date.accessioned2024-05-17T10:27:50Z
dc.date.available2024-05-17T10:27:50Z
dc.date.issued2023-08-03
dc.identifier.citationZhao, Y., Tabet, D., Rubio Contreras, D., Lao, L., Kousholt, A.N., Weile, J.,...,Durocher, D. (2023). Genome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screens. Molecular Cell, 83 (15), 2792-2809. https://doi.org/10.1016/j.molcel.2023.06.025.
dc.identifier.issn1097-2765es
dc.identifier.issn1097-4164es
dc.identifier.urihttps://hdl.handle.net/11441/158498
dc.description.abstractTo maintain genome integrity, cells must accurately duplicate their genome and repair DNA lesions when they occur. To uncover genes that suppress DNA damage in human cells, we undertook flow-cytometry-based CRISPR-Cas9 screens that monitored DNA damage. We identified 160 genes whose mutation caused spontaneous DNA damage, a list enriched in essential genes, highlighting the importance of genomic integrity for cellular fitness. We also identified 227 genes whose mutation caused DNA damage in replication-perturbed cells. Among the genes characterized, we discovered that deoxyribose-phosphate aldolase DERA suppresses DNA damage caused by cytarabine (Ara-C) and that GNB1L, a gene implicated in 22q11.2 syndrome, promotes biogenesis of ATR and related phosphatidylinositol 3-kinase-related kinases (PIKKs). These results implicate defective PIKK biogenesis as a cause of some phenotypes associated with 22q11.2 syndrome. The phenotypic mapping of genes that suppress DNA damage therefore provides a rich resource to probe the cellular pathways that influence genome maintenancees
dc.description.sponsorshipNational Institutes of Health (NIH). Estados Unidos RM1HG010461 - UM1HG011989es
dc.description.sponsorshipCanadian Cancer Society 705644es
dc.description.sponsorshipCanadian Institutes of Health Research CIHR PJT-180438 - FDN159926es
dc.formatapplication/pdfes
dc.format.extent17es
dc.language.isoenges
dc.publisherCell Presses
dc.relation.ispartofMolecular Cell, 83 (15), 2792-2809.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleGenome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screenses
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Genéticaes
dc.relation.projectIDRM1HG010461es
dc.relation.projectIDUM1HG011989es
dc.relation.projectID705644es
dc.relation.projectIDPJT-180438es
dc.relation.projectIDFDN159926es
dc.relation.publisherversionhttps://doi.org/10.1016/j.molcel.2023.06.025es
dc.identifier.doi10.1016/j.molcel.2023.06.025es
dc.journaltitleMolecular Celles
dc.publication.volumen83es
dc.publication.issue15es
dc.publication.initialPage2792es
dc.publication.endPage2809es
dc.contributor.funderNational Institutes of Health (NIH). Estados Unidoses
dc.contributor.funderCanadian Cancer Society. Canadaes
dc.contributor.funderCanadian Institutes of Health Research CIHRes

FicherosTamañoFormatoVerDescripción
PIIS1097276523004720.pdf9.141MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional